Pathogenicity and virulence of Mycobacterium leprae

References

• Lastoria JC, Abreu MA. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. An Bras Dermatol. 2014;89(2):205–218.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Chaudhuri S. Chronicles of Gerhard-Henrik Armauer Hansen’s life and work. Indian J Dermatol. 2015;60(3):219–221.
   PubMed Web of Science ®Google Scholar
• Han XY, Seo YH, Sizer KC, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol. 2008;130(6):856–864. DOI:10.1309/AJCPP72FJZZRRVMM
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Wkly Epidemiol Rec. 2020;95(36):417–440.
   Google Scholar
• Ogunsumi DO, Lal V, Puchner KP, et al. Measuring endemicity and burden of leprosy across countries and regions: a systematic review and Delphi survey. PLoS Negl Trop Dis. 2021;15(9):e0009769. DOI:10.1371/journal.pntd.0009769
   PubMed Web of Science ®Google Scholar
• World Health Organization. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser. 1982;675:1–33.
   PubMedGoogle Scholar
• World Health Organization. Neglected tropical diseases; 2021 [cited 2022 May 13]. Available from: https://www.who.int/news-room/questions-and-answers/item/neglected-tropical-diseases
   Google Scholar
• World Health Organization. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021–2030;2021. Geneva: WHO.
   Google Scholar
• World Health Organization. Towards zero leprosy. Global Leprosy (‎Hansen’s Disease)‎ Strategy 2021–20302021.
   Google Scholar
• Young RA, Mehra V, Sweetser D, et al. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature. 1985;316(6027):450–452. DOI:10.1038/316450a0
   PubMed Web of Science ®Google Scholar
• World Health Organization. Leprosy; 2022 [cited 2022 May 13]. Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy
   Google Scholar
• World Health Organization. WHO supports implementation of Global Leprosy Program at national level; 2017 [cited 2022 May 13]. Available from: https://www.afro.who.int/news/who-supports-implementation-global-leprosy-program-national-level
   Google Scholar
• World Health OrganizationMonitoring grade-2 disability rate and applicability of chemoprophylaxis in leprosy control. London, United Kingdom: WHO Regional Office for South-East Asia; 2009 [cited 2009 Nov 12-13].
   Google Scholar
• Lazo-Porras M, Prutsky GJ, Barrionuevo P, et al. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):62. DOI:10.1186/s12879-019-4665-0
   PubMed Web of Science ®Google Scholar
• Tanigawa K, Hayashi Y, Hama K, et al. Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells. PLoS One. 2021;16(3):e0249184. DOI:10.1371/journal.pone.0249184
   PubMed Web of Science ®Google Scholar
• Desikan KV. Extended studies on the viability of Mycobacterium leprae outside the human body. Lepr Rev. 1995;66(4):287–295.
   PubMed Web of Science ®Google Scholar
• Lastória JC, MAMMd A. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. An Bras Dermatol. 2014;89(2):205–218.
   PubMed Web of Science ®Google Scholar
• Cocito C, Delville J. Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients. Eur J Epidemiol. 1985;1(3):202–231.
   PubMedGoogle Scholar
• Murray PR. Manual of clinical microbiology. Washington, D.C: ASM Press; 1995.
   Google Scholar
• Rees R, Young D. The microbiology of leprosy, 49-83. New York, NY: Leprosy Churchill Livingstone; 1994.
   Google Scholar
• Jacobson RR, Krahenbuhl JL. Leprosy. Lancet. 1999;353(9153):655–660.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Takeshita F, Okuda K, et al. Mycobacterium leprae and leprosy: a compendium. Microbiol Immunol. 2001;45(11):729–736.
   PubMed Web of Science ®Google Scholar
• Shepard CC. The first decade in experimental leprosy. Bull World Health Organ. 1971;44(6):821–827.
   PubMed Web of Science ®Google Scholar
• Hastings RC, Brand PW, Mansfield RE, et al. Bacterial density in the skin in lepromatous leprosy as related to temperature. Lepr Rev. 1968;39(2):71–74.
   PubMedGoogle Scholar
• Shepard CC. Temperature optimum of Mycobacterium leprae in mice. J Bacteriol. 1965;90(5):1271–1275.
   PubMed Web of Science ®Google Scholar
• Desikan KV. Viability of Mycobacterium leprae outside the human body. Lepr Rev. 1977;48(4):231–235.
   PubMed Web of Science ®Google Scholar
• Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis. 2003;83(1–3):91–97.
   PubMed Web of Science ®Google Scholar
• Daffe M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol. 1998;39:131–203.
   PubMed Web of Science ®Google Scholar
• Eichelmann K, Gonzalez Gonzalez SE, Salas-Alanis JC, et al. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104(7):554–563.
   PubMedGoogle Scholar
• Hirata T. Electron microscopic observations of cell wall and cytoplasmic membrane in murine and human leprosy bacilli. Int J Lepr Other Mycobact Dis. 1985;53(3):433–440.
   PubMedGoogle Scholar
• Hett EC, Rubin EJ. Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev. 2008;72(1):126–156.
   PubMed Web of Science ®Google Scholar
• Dhariwal KR, Yang YM, Fales HM, et al. Detection of trehalose monomycolate in Mycobacterium leprae grown in armadillo tissues. J Gen Microbiol. 1987;133(1):201–209.
   PubMedGoogle Scholar
• Brennan PJ. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis. 1989;11(Suppl 2):S420–30.
   PubMedGoogle Scholar
• Hunter SW, Fujiwara T, Brennan PJ. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem. 1982;257(24):15072–15078.
   PubMed Web of Science ®Google Scholar
• Soares BA, Stanke Scandelari JP, Wagatuma Bottolo BM, et al. Chapter 30 - engineered biomarkers for immunodiagnosis of leprosy. In: Faintuch J S Faintuch, editors. Precision medicine for investigators, practitioners and providers. Academic Press; 2020. p. 309–317.
   Google Scholar
• Spencer JS, Brennan PJ. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr Rev. 2011;82(4):344–357.
   PubMed Web of Science ®Google Scholar
• Díaz Acosta CC, Dias AA, TLSA R, et al. PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves. PLoS Pathog. 2018;14(7):e1007151. DOI:10.1371/journal.ppat.1007151
   PubMed Web of Science ®Google Scholar
• Arbues A, Lugo-Villarino G, Neyrolles O, et al. Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids. Front Cell Infect Microbiol. 2014;4:173.
   PubMed Web of Science ®Google Scholar
• Wu QX, Ye GY, Li XY. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls. Int J Lepr Other Mycobact Dis. 1988;56(1):50–55.
   PubMedGoogle Scholar
• Zhang J, Chatterjee D, Brennan PJ, et al. A modified synthesis and serological evaluation of neoglycoproteins containing the natural disaccharide of PGL-I from Mycobacterium leprae. Bioorg Med Chem Lett. 2010;20(11):3250–3253.
   PubMed Web of Science ®Google Scholar
• MDPSA S, Lima MFD, LNGC L. Sensitivity of Anti-PGL-1 Elisa test using mixed antigens (disaccharide + trisaccharide) for the diagnosis and epidemiological surveillance of leprosy. Lepr Rev. 2018;89(4):376–386.
   Web of Science ®Google Scholar
• Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology. 1998;8(2):113–120.
   PubMed Web of Science ®Google Scholar
• Kaplan G, Gandhi RR, Weinstein DE, et al. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol. 1987;138(9):3028–3034.
   PubMed Web of Science ®Google Scholar
• Sibley LD, Hunter SW, Brennan PJ, et al. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun. 1988;56(5):1232–1236.
   PubMed Web of Science ®Google Scholar
• Chan J, Fan XD, Hunter SW, et al. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun. 1991;59(5):1755–1761.
   PubMed Web of Science ®Google Scholar
• Chatterjee D, Roberts AD, Lowell K, et al. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun. 1992;60(3):1249–1253.
   PubMed Web of Science ®Google Scholar
• Adams LB, Fukutomi Y, Krahenbuhl JL. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun. 1993;61(10):4173–4181.
   PubMed Web of Science ®Google Scholar
• Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64(1):29–63.
   PubMedGoogle Scholar
• Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972;36(4):407–477.
   PubMedGoogle Scholar
• Kotani S, Yanagida I, Kato K, et al. Studies on peptides, glycopeptides and antigenic polysaccharide-glycopeptide complexes isolated from an L-11 enzyme lysate of the cell walls of Mycobacterium tuberculosis strain H37Rv. Biken J. 1970;13(4):249–275.
   PubMedGoogle Scholar
• Petit JF, Adam A, Wietzerbin-Falszpan J, et al. Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun. 1969;35(4):478–485.
   PubMed Web of Science ®Google Scholar
• Petit JF, Wietzerbin J, Das BC, et al. Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Z Immunitatsforsch Exp Klin Immunol. 1975;149(2–4):118–125.
   PubMedGoogle Scholar
• Mahapatra S, Yagi T, Belisle JT, et al. Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J Bacteriol. 2005;187(8):2747–2757. DOI:10.1128/JB.187.8.2747-2757.2005
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Scherman H, Brennan PJ, et al. N Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J Bacteriol. 2005;187(7):2341–2347.
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Crick DC, McNeil MR, et al. Unique structural features of the peptidoglycan of Mycobacterium leprae. J Bacteriol. 2008;190(2):655–661.
   PubMed Web of Science ®Google Scholar
• Mahapatra S, Crick DC, Brennan PJ. Comparison of the UDP-N-Acetylmuramate: l-Alanine Ligase Enzymes from Mycobacterium tuberculosis and Mycobacterium leprae. J Bacteriol. 2000;182(23):6827–6830.
   PubMed Web of Science ®Google Scholar
• Draper P, Kandler O, Darbre A. Peptidoglycan and arabinogalactan of Mycobacterium leprae. J Gen Microbiol. 1987;133(5):1187–1194.
   PubMedGoogle Scholar
• Girardin SE, Travassos LH, Hervé M, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 2003;278(43):41702–41708. DOI:10.1074/jbc.M307198200
   PubMed Web of Science ®Google Scholar
• Roychowdhury A, Wolfert MA, Boons GJ. Synthesis and proinflammatory properties of muramyl tripeptides containing lysine and diaminopimelic acid moieties. Chembiochem. 2005;6(11):2088–2097.
   PubMed Web of Science ®Google Scholar
• Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem. 2003;278(8):5509–5512. DOI:10.1074/jbc.C200673200
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537–544. DOI:10.1038/31159
   PubMed Web of Science ®Google Scholar
• Cole ST, Eiglmeier K, Parkhill J, et al. Massive gene decay in the leprosy bacillus. Nature. 2001;409(6823):1007–1011. DOI:10.1038/35059006
   PubMed Web of Science ®Google Scholar
• Singh P, Cole ST. Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future Microbiol. 2011;6(1):57–71.
   PubMed Web of Science ®Google Scholar
• Vissa VD, Brennan PJ. The genome of Mycobacterium leprae: a minimal mycobacterial gene set. Genome Biol. 2001;2(8):REVIEWS1023.
   PubMedGoogle Scholar
• Wheeler PR. The microbial physiologist’s guide to the leprosy genome. Lepr Rev. 2001;72(4):399–407.
   PubMed Web of Science ®Google Scholar
• Akama T, Suzuki K, Tanigawa K, et al. Whole-genome tiling array analysis of Mycobacterium leprae RNA reveals high expression of pseudogenes and noncoding regions. J Bacteriol. 2009;191(10):3321–3327. DOI:10.1128/JB.00120-09
   PubMed Web of Science ®Google Scholar
• Williams DL, Slayden RA, Amin A, et al. Implications of high level pseudogene transcription in Mycobacterium leprae. BMC Genomics. 2009;10(1):397. DOI:10.1186/1471-2164-10-397
   PubMedGoogle Scholar
• Cole ST, Supply P, Honore N. Repetitive sequences in Mycobacterium leprae and their impact on genome plasticity. Lepr Rev. 2001;72(4):449–461.
   PubMed Web of Science ®Google Scholar
• Williams DL, Gillis TP, Portaels F. Geographically distinct isolates of Mycobacterium leprae exhibit no genotypic diversity by restriction fragment-length polymorphism analysis. Mol Microbiol. 1990;4(10):1653–1659.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Akama T, Bang PD, et al. Detection of RNA expression from pseudogenes and non-coding genomic regions of Mycobacterium leprae. Microb Pathog. 2009;47(3):183–187. DOI:10.1016/j.micpath.2009.06.006
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakata N, Bang PD, et al. High-level expression of pseudogenes in Mycobacterium leprae. FEMS Microbiol Lett. 2006;259(2):208–214.
   PubMed Web of Science ®Google Scholar
• Tanigawa K, Degang Y, Kawashima A, et al. Essential role of hormone-sensitive lipase (HSL) in the maintenance of lipid storage in Mycobacterium leprae-infected macrophages. Microb Pathog. 2012;52(5):285–291. DOI:10.1016/j.micpath.2012.02.003
   PubMed Web of Science ®Google Scholar
• Akama T, Suzuki K, Tanigawa K, et al. Whole-genome expression analysis of Mycobacterium leprae and its clinical application. Jpn J Infect Dis. 2010;63(6):387–392. DOI:10.7883/yoken.63.387
   PubMed Web of Science ®Google Scholar
• Akama T, Tanigawa K, Kawashima A, et al. Analysis of Mycobacterium leprae gene expression using DNA microarray. Microb Pathog. 2010;49(4):181–185.
   PubMed Web of Science ®Google Scholar
• Degang Y, Akama T, Hara T, et al. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages. PLoS Negl Trop Dis. 2012;6(12):e1936. DOI:10.1371/journal.pntd.0001936
   PubMed Web of Science ®Google Scholar
• Luo Y, Tanigawa K, Kawashima A, et al. The function of peroxisome proliferator-activated receptors PPARγ and PPARδ in Mycobacterium leprae-induced foam cell formation in host macrophages. PLoS Negl Trop Dis. 2020;14(10):e0008850.
   PubMed Web of Science ®Google Scholar
• Kimura M, Sakamuri RM, Groathouse NA, et al. Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens. J Clin Microbiol. 2009;47(6):1757–1766. DOI:10.1128/JCM.02019-08
   PubMed Web of Science ®Google Scholar
• Zhang L, Budiawan T, Matsuoka M. Diversity of potential short tandem repeats in Mycobacterium leprae and application for molecular typing. J Clin Microbiol. 2005;43(10):5221–5229.
   PubMed Web of Science ®Google Scholar
• Truman R, Fontes AB, De Miranda AB, et al. Genotypic variation and stability of four variable-number tandem repeats and their suitability for discriminating strains of Mycobacterium leprae. J Clin Microbiol. 2004;42(6):2558–2565.
   PubMed Web of Science ®Google Scholar
• Groathouse NA, Rivoire B, Kim H, et al. Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae. J Clin Microbiol. 2004;42(4):1666–1672. DOI:10.1128/JCM.42.4.1666-1672.2004
   PubMed Web of Science ®Google Scholar
• Avanzi C, Busso P, Benjak A, et al. Transmission of drug-resistant leprosy in Guinea-Conakry detected using molecular epidemiological approaches. Clin Infect Dis. 2016;63(11):1482–1484. DOI:10.1093/cid/ciw572
   PubMed Web of Science ®Google Scholar
• Schuenemann VJ, Avanzi C, Krause-Kyora B, et al. Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe. PLoS Pathog. 2018;14(5):e1006997. DOI:10.1371/journal.ppat.1006997
   PubMed Web of Science ®Google Scholar
• Monot M, Honore N, Garnier T, et al. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet. 2009;41(12):1282–1289. DOI:10.1038/ng.477
   PubMed Web of Science ®Google Scholar
• Monot M, Honore N, Garnier T, et al. On the origin of leprosy. Science. 2005;308(5724):1040–1042. DOI:10.1126/science/1109759
   PubMed Web of Science ®Google Scholar
• Sharma R, Singh P, Loughry WJ, et al. Zoonotic leprosy in the Southeastern United States. Emerg Infect Dis. 2015;21(12):2127–2134. DOI:10.3201/eid2112.150501
   PubMed Web of Science ®Google Scholar
• Cardona-Castro N, Beltran-Alzate JC, Romero-Montoya IM, et al. Identification and comparison of Mycobacterium leprae genotypes in two geographical regions of Colombia. Lepr Rev. 2009;80(3):316–321.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Gonzalez AV, Estrada I, et al. Various genotypes of Mycobacterium leprae from Mexico reveal distinct geographic distribution. Lepr Rev. 2009;80(3):322–326.
   PubMed Web of Science ®Google Scholar
• Srisungnam S, Rudeeaneksin J, Lukebua A, et al. Molecular epidemiology of leprosy based on VNTR typing in Thailand. Lepr Rev. 2009;80(3):280–289. DOI:10.47276/lr.80.3.280
   PubMed Web of Science ®Google Scholar
• Sakamuri RM, Kimura M, Li W, et al. Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol. 2009;47(9):2844–2854. DOI:10.1128/JCM.02021-08
   PubMed Web of Science ®Google Scholar
• Fontes AN, Sakamuri RM, Baptista IM, et al. Genetic diversity of Mycobacterium leprae isolates from Brazilian leprosy patients. Lepr Rev. 2009;80(3):302–315. DOI:10.47276/lr.80.3.302
   PubMed Web of Science ®Google Scholar
• Lavania M, Jadhav R, Turankar RP, et al. Genotyping of Mycobacterium leprae strains from a region of high endemic leprosy prevalence in India. Infect Genet Evol. 2015;36:256–261.
   PubMed Web of Science ®Google Scholar
• Lavania M, Jadhav RS, Turankar RP, et al. Single nucleotide polymorphisms typing of Mycobacterium leprae reveals focal transmission of leprosy in high endemic regions of India. Clin Microbiol Infect. 2013;19(11):1058–1062.
   PubMed Web of Science ®Google Scholar
• Das M, Chaitanya VS, Kanmani K, et al. Genomic diversity in Mycobacterium leprae isolates from leprosy cases in South India. Infect Genet Evol. 2016;45:285–289.
   PubMed Web of Science ®Google Scholar
• Singh P, Benjak A, Carat S, et al. Genome-wide re-sequencing of multidrug-resistant Mycobacterium leprae Airaku-3. Clin Microbiol Infect. 2014;20(10):O619–22. DOI:10.1111/1469-0691.12609
   PubMed Web of Science ®Google Scholar
• Schuenemann VJ, Singh P, Mendum TA, et al. Genome-wide comparison of medieval and modern Mycobacterium leprae. Science. 2013;341(6142):179–183. DOI:10.1126/science.1238286
   PubMed Web of Science ®Google Scholar
• Benjak A, Avanzi C, Singh P, et al. Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae. Nat Commun. 2018;9(1):352. DOI:10.1038/s41467-017-02576-z
   PubMed Web of Science ®Google Scholar
• Truman RW, Singh P, Sharma R, et al. Probable zoonotic leprosy in the Southern United States. N Engl J Med. 2011;364(17):1626–1633. DOI:10.1056/NEJMoa1010536
   PubMed Web of Science ®Google Scholar
• Singh P, Benjak A, Schuenemann VJ, et al. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis. Proc Natl Acad Sci. 2015;112(14):4459–4464. DOI:10.1073/pnas.1421504112
   PubMed Web of Science ®Google Scholar
• Truman RW, Shannon EJ, Hagstad HV, et al. Evaluation of the origin of Mycobacterium leprae infections in the wild armadillo, Dasypus novemcinctus. Am J Trop Med Hyg. 1986;35(3):588–593.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Udono T, Fujisawa M, et al. Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical research. J Clin Microbiol. 2010;48(9):3432–3434.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Tanigawa K, Kawashima A, et al. Chimpanzees used for medical research shed light on the pathoetiology of leprosy. Future Microbiol. 2011;6(10):1151–1157.
   PubMed Web of Science ®Google Scholar
• Honap TP, Pfister LA, Housman G, et al. Mycobacterium leprae genomes from naturally infected nonhuman primates. PLoS Negl Trop Dis. 2018;12(1):e0006190. DOI:10.1371/journal.pntd.0006190
   PubMed Web of Science ®Google Scholar
• Hagge DA, Parajuli P, Kunwar CB, et al. Opening a can of worms: leprosy reactions and complicit soil-transmitted helminths. EBioMedicine. 2017;23:119–124.
   PubMed Web of Science ®Google Scholar
• Ramu G, Desikan KV. A study of scrotal biopsy in subsided cases of lepromatous leprosy. Lepr India. 1979;51(3):341–347.
   PubMedGoogle Scholar
• Shetty VP, Suchitra K, Uplekar MW, et al. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy. Lepr Rev. 1997;68(2):131–138.
   PubMed Web of Science ®Google Scholar
• Jin S-H, Ahn KJ, An S. Importance of the immune response to Mycobacterium leprae in the skin. Biomed Dermatol. 2018;2(1):1.
   Google Scholar
• Sampaio LH, Stefani MM, Oliveira RM, et al. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis. 2011;11(1):26. DOI:10.1186/1471-2334-11-26
   PubMedGoogle Scholar
• Kumar A, Parkash O, Girdhar BK. Analysis of antigens of Mycobacterium leprae by interaction to sera IgG, IgM, and IgA response to improve diagnosis of leprosy. Biomed Res Int. 2014;2014:283278.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2(8):675–680.
   PubMed Web of Science ®Google Scholar
• Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003;170(7):3451–3454.
   PubMed Web of Science ®Google Scholar
• Tanigawa K, Suzuki K, Nakamura K, et al. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol Lett. 2008;289(1):72–79. DOI:10.1111/j.1574-6968.2008.01369.x
   PubMed Web of Science ®Google Scholar
• Kang TJ, Chae GT. The role of intracellular receptor NODs for cytokine production by macrophages infected with Mycobacterium leprae. Immune Netw. 2011;11(6):424–427.
   PubMedGoogle Scholar
• Schenk M, Mahapatra S, Le P, et al. Human NOD2 recognizes structurally unique muramyl dipeptides from Mycobacterium leprae. Infect Immun. 2016;84(9):2429–2438. DOI:10.1128/IAI.00334-16
   PubMed Web of Science ®Google Scholar
• Schenk M, Krutzik SR, Sieling PA, et al. NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med. 2012;18(4):555–563. DOI:10.1038/nm.2650
   PubMed Web of Science ®Google Scholar
• Jin MS, Kim SE, Heo JY, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130(6):1071–1082. DOI:10.1016/j.cell.2007.09.008
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Ochoa MT, Sieling PA, et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 2003;9(5):525–532. DOI:10.1038/nm864
   PubMed Web of Science ®Google Scholar
• Kang JY, Nan X, Jin MS, et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity. 2009;31(6):873–884. DOI:10.1016/j.immuni.2009.09.018
   PubMed Web of Science ®Google Scholar
• Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol. 2012;3:79.
   PubMed Web of Science ®Google Scholar
• Carl VS, Brown-Steinke K, Nicklin MJ, et al. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages. J Biol Chem. 2002;277(20):17448–17456.
   PubMed Web of Science ®Google Scholar
• Tapping RI, Tobias PS. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J Endotoxin Res. 2003;9(4):264–268.
   PubMedGoogle Scholar
• Polycarpou A, Holland MJ, Karageorgiou I, et al. Mycobacterium leprae activates Toll-like receptor-4 signaling and expression on macrophages depending on previous bacillus Calmette-Guerin vaccination. Front Cell Infect Microbiol. 2016;6:72.
   PubMed Web of Science ®Google Scholar
• Dias AA, Silva C, da Silva CO, et al. TLR-9 plays a role in Mycobacterium leprae-induced innate immune activation of A549 alveolar epithelial cells. Front Immunol. 2021;12:657449.
   PubMed Web of Science ®Google Scholar
• Leturiondo AL, Noronha AB, Mendonca CYR, et al. Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population. PLoS Negl Trop Dis. 2020;14(5):e0008247. DOI:10.1371/journal.pntd.0008247
   PubMed Web of Science ®Google Scholar
• Salgame P, Yamamura M, Bloom BR, et al. Evidence for functional subsets of CD4+ and CD8+ T cells in human disease: lymphokine patterns in leprosy. Chem Immunol. 1992;54:44–59.
   PubMedGoogle Scholar
• Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol. 1994;102(6):828–832.
   PubMed Web of Science ®Google Scholar
• Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull. 2006;77-78(1):103–121.
   PubMedGoogle Scholar
• Cho SN, Cellona RV, Villahermosa LG, et al. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin Diagn Lab Immunol. 2001;8(1):138–142. DOI:10.1128/CDLI.8.1.138-142.2001
   PubMedGoogle Scholar
• Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255–273.
   PubMedGoogle Scholar
• Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991;254(5029):277–279. DOI:10.1126/science.254.5029.277
   PubMed Web of Science ®Google Scholar
• Towers TL, Freedman LP. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem. 1998;273(17):10338–10348.
   PubMed Web of Science ®Google Scholar
• Yamamura M, Wang XH, Ohmen JD, et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol. 1992;149(4):1470–1475.
   PubMed Web of Science ®Google Scholar
• Bhat RM, Prakash C. Leprosy: an overview of pathophysiology. Interdiscip Perspect Infect Dis. 2012;2012:181089.
   PubMedGoogle Scholar
• Massone C, Nunzi E, Ribeiro-Rodrigues R, et al. T regulatory cells and plasmocytoid dentritic cells in Hansen disease: a new insight into pathogenesis? Am J Dermatopathol. 2010;32(3):251–256. DOI:10.1097/DAD.0b013e3181b7fc56
   PubMed Web of Science ®Google Scholar
• Parente JN, Talhari C, Schettini AP, et al. T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states. An Bras Dermatol. 2015;90(1):41–47.
   PubMed Web of Science ®Google Scholar
• Attia EA, Abdallah M, Saad AA, et al. Circulating CD4+ CD25 high FoxP3+ T cells vary in different clinical forms of leprosy. Int J Dermatol. 2010;49(10):1152–1158. DOI:10.1111/j.1365-4632.2010.04535.x
   PubMed Web of Science ®Google Scholar
• Palermo ML, Pagliari C, Trindade MA, et al. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy. Am J Trop Med Hyg. 2012;86(5):878–883. DOI:10.4269/ajtmh.2012.12-0088
   PubMed Web of Science ®Google Scholar
• Sadhu S, Khaitan BK, Joshi B, et al. Reciprocity between regulatory T cells and Th17 cells: relevance to polarized immunity in leprosy. PLoS Negl Trop Dis. 2016;10(1):e0004338.
   PubMed Web of Science ®Google Scholar
• Saini C, Siddiqui A, Ramesh V, et al. Leprosy reactions show increased Th17 cell activity and reduced FOXP3+ tregs with concomitant decrease in TGF-β and increase in IL-6. PLoS Negl Trop Dis. 2016;10(4):e0004592.
   PubMed Web of Science ®Google Scholar
• Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways. J Invest Dermatol. 2015;135(9):2198–2208. DOI:10.1038/jid.2015.141
   PubMed Web of Science ®Google Scholar
• Saini C, Ramesh V, Nath I. CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy. PLoS Negl Trop Dis. 2013;7(7):e2338.
   PubMed Web of Science ®Google Scholar
• Chaitanya S, Lavania M, Turankar RP, et al. Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy. J Clin Immunol. 2012;32(6):1415–1420.
   PubMed Web of Science ®Google Scholar
• Saini C, Tarique M, Rai R, et al. T helper cells in leprosy: an update. Immunol Lett. 2017;184:61–66.
   PubMed Web of Science ®Google Scholar
• Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci. 2018;19(6):1801.
   PubMed Web of Science ®Google Scholar
• Sica A, Erreni M, Allavena P, et al. Macrophage polarization in pathology. Cell Mol Life Sci. 2015;72(21):4111–4126.
   PubMed Web of Science ®Google Scholar
• Gordon S, Pluddemann A. Tissue macrophages: heterogeneity and functions. BMC Biol. 2017;15(1):53.
   PubMedGoogle Scholar
• Schlesinger LS, Horwitz MA. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (Cd11b/CD18), and CR4 (Cd11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol. 1991;147(6):1983–1994.
   PubMed Web of Science ®Google Scholar
• Saqib U, Sarkar S, Suk K, et al. Phytochemicals as modulators of M1-M2 macrophages in inflammation. Oncotarget. 2018;9(25):17937–17950.
   PubMedGoogle Scholar
• de Sousa JR, de Sousa RPM, de Souza Aarão TL, et al. Response of iNOS and its relationship with IL-22 and STAT3 in macrophage activity in the polar forms of leprosy. Acta Trop. 2017;171:74–79.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.
   PubMed Web of Science ®Google Scholar
• Kibbie J, Teles RM, Wang Z, et al. Jagged1 instructs macrophage differentiation in leprosy. PLoS Pathog. 2016;12(8):e1005808. DOI:10.1371/journal.ppat.1005808
   PubMed Web of Science ®Google Scholar
• de Sousa JR, de Sousa RP, Aarao TL, et al. In situ expression of M2 macrophage subpopulation in leprosy skin lesions. Acta Trop. 2016;157:108–114.
   PubMed Web of Science ®Google Scholar
• Moura DF, de Mattos KA, Amadeu TP, et al. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. Eur J Immunol. 2012;42(11):2925–2936. DOI:10.1002/eji.201142198
   PubMed Web of Science ®Google Scholar
• de Souza Sales J, Lara FA, Amadeu TP, et al. The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Clin Exp Immunol. 2011;165(2):251–263. DOI:10.1111/j.1365-2249.2011.04412.x
   PubMed Web of Science ®Google Scholar
• Terpstra V, Bird DA, Steinberg D. Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc Natl Acad Sci U S A. 1998;95(4):1806–1811.
   PubMed Web of Science ®Google Scholar
• Montoya D, Cruz D, Teles RM, et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe. 2009;6(4):343–353. DOI:10.1016/j.chom.2009.09.002
   PubMed Web of Science ®Google Scholar
• Oksala NKJ, Seppälä I, Rahikainen R, et al. Synergistic expression of histone deacetylase 9 and matrix metalloproteinase 12 in M4 macrophages in advanced carotid plaques. Eur J Vasc Endovasc Surg. 2017;53(5):632–640. DOI:10.1016/j.ejvs.2017.02.014
   PubMed Web of Science ®Google Scholar
• de Sousa JR, Lucena Neto FD, Sotto MN, et al. Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions. BMC Infect Dis. 2018;18(1):576.
   PubMedGoogle Scholar
• Erbel C, Tyka M, Helmes CM, et al. CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo. Innate Immun. 2015;21(3):255–265. DOI:10.1177/1753425914526461
   PubMed Web of Science ®Google Scholar
• Ferrari G, Langen H, Naito M, et al. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell. 1999;97(4):435–447.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Takeshita F, Nakata N, et al. Localization of CORO1A in the macrophages containing Mycobacterium leprae. Acta Histochem Cytochem. 2006;39(4):107–112.
   PubMed Web of Science ®Google Scholar
• Tanigawa K, Suzuki K, Kimura H, et al. Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Clin Exp Immunol. 2009;156(3):495–501. DOI:10.1111/j.1365-2249.2009.03930.x
   PubMed Web of Science ®Google Scholar
• Johnstone PA. The search for animal models of leprosy. Int J Lepr Other Mycobact Dis. 1987;55(3):535–547.
   PubMedGoogle Scholar
• Truman RW, Krahenbuhl JL. Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis. 2001;69(1):1–12.
   PubMedGoogle Scholar
• Shepard CC. The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med. 1960;112(3):445–454.
   PubMed Web of Science ®Google Scholar
• Welch TM, Gelber RH, Murray LP, et al. Viability of Mycobacterium leprae after multiplication in mice. Infect Immun. 1980;30(2):325–328.
   PubMed Web of Science ®Google Scholar
• Rees RJ. Limited multiplication of acid-fast bacilli in the foot-pads of mice inoculated with Mycobacterium leprae. Br J Exp Pathol. 1964;45(2):207–218.
   PubMedGoogle Scholar
• Rees RJ. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966;211(5049):657–658.
   PubMed Web of Science ®Google Scholar
• Adams LB. Susceptibility and resistance in leprosy: studies in the mouse model. Immunol Rev. 2021;301(1):157–174.
   PubMed Web of Science ®Google Scholar
• Chehl S, Ruby J, Job CK, et al. The growth of Mycobacterium leprae in nude mice. Lepr Rev. 1983;54(4):283–304.
   PubMed Web of Science ®Google Scholar
• Colston MJ, Hilson GR. Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature. 1976;262(5567):399–401.
   PubMed Web of Science ®Google Scholar
• Converse PJ, Haines VL, Wondimu A, et al. Infection of SCID mice with Mycobacterium leprae and control with antigen-activated “immune” human peripheral blood mononuclear cells. Infect Immun. 1995;63(3):1047–1054.
   PubMed Web of Science ®Google Scholar
• Yogi Y, Fujimura T, Suzuki K. History for animal model of Hansen’s disease and characteristics of leprosy in hypertensive nude rat. Jpn J Lepr. 2008;77(3):197–204.
   Google Scholar
• Yogi Y, Banba T, Kobayashi M, et al. Leprosy in hypertensive nude rats (Shr/ncrj-rnu). Int J Lepr Other Mycobact Dis. 1999;67(4):435–445.
   PubMedGoogle Scholar
• Loughry W, McDonough C. The Nine-Banded Armadillo: a natural history. Oklahoma: University of Oklahoma Press; 2013.
   Google Scholar
• Kirchheimer WF, Storrs EE. Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo. Int J Lepr Other Mycobact Dis. 1971;39(3):693–702.
   PubMedGoogle Scholar
• Peña MT, Adams JE, Adams LB, et al. Expression and characterization of recombinant interferon gamma (IFNγ) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages. Cytokine. 2008;43(2):124–131. DOI:10.1016/j.cyto.2008.04.014
   PubMed Web of Science ®Google Scholar
• Scollard DM. The biology of nerve injury in leprosy. Lepr Rev. 2008;79(3):242–253.
   PubMed Web of Science ®Google Scholar
• Truman RW, Ebenezer GJ, Pena MT, et al. The armadillo as a model for peripheral neuropathy in leprosy. Ilar J. 2014;54(3):304–314. DOI:10.1093/ilar/ilt050
   PubMed Web of Science ®Google Scholar
• Swaim LE, Connolly LE, Volkman HE, et al. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun. 2006;74(11):6108–6117.
   PubMed Web of Science ®Google Scholar
• Madigan CA, Cambier CJ, Kelly-Scumpia KM, et al. A macrophage response to Mycobacterium leprae phenolic glycolipid initiates nerve damage in leprosy. Cell. 2017;170(5):973–85 e10. DOI:10.1016/j.cell.2017.07.030
   PubMed Web of Science ®Google Scholar
• Levy L, Ji B. The mouse foot-pad technique for cultivation of Mycobacterium leprae. Lepr Rev. 2006;77(1):5–24.
   PubMed Web of Science ®Google Scholar
• Ebenezer GJ, Norman G, Joseph GA, et al. Drug resistant-Mycobacterium leprae–results of mouse footpad studies from a laboratory in south India. Indian J Lepr. 2002;74(4):301–312.
   PubMedGoogle Scholar
• Pattyn SR. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes. Acta Leprol. 1983;1(1):29–32.
   PubMedGoogle Scholar
• Meyers WM, Gormus BJ, Walsh GP, et al. Naturally acquired and experimental leprosy in nonhuman primates. Am J Trop Med Hyg. 1991;44(4 Pt 2):24–27.
   PubMed Web of Science ®Google Scholar
• Walsh GP, Dela Cruz EC, Abalos RM, et al. Limited susceptibility of cynomolgus monkeys (Macaca fascicularis) to leprosy after experimental administration of Mycobacterium leprae. Am J Trop Med Hyg. 2012;87(2):327–336. DOI:10.4269/ajtmh.2012.11-0780
   PubMed Web of Science ®Google Scholar
• Bratschi MW, Steinmann P, Wickenden A, et al. Current knowledge on Mycobacterium leprae transmission: a systematic literature review. Lepr Rev. 2015;86(2):142–155.
   PubMed Web of Science ®Google Scholar
• Mensah-Awere D, Bratschi MW, Steinmann P, et al. Symposium report: developing strategies to block the transmission of leprosy. Lepr Rev. 2015;86(2):156–164.
   PubMed Web of Science ®Google Scholar
• Duncan ME. Leprosy in children one year of age and under. Int J Lepr Other Mycobact Dis. 1986;54(4):646.
   PubMedGoogle Scholar
• Brubaker ML, Meyers WM, Bourland J. Leprosy in children one year of age and under. Int J Lepr Other Mycobact Dis. 1985;53(4):517–523.
   PubMedGoogle Scholar
• Balamayooran G, Pena M, Sharma R, et al. The armadillo as an animal model and reservoir host for Mycobacterium leprae. Clin Dermatol. 2015;33(1):108–115.
   PubMed Web of Science ®Google Scholar
• Cardona-Castro N, Beltran JC, Ortiz-Bernal A, et al. Detection of Mycobacterium leprae DNA in nine-banded armadillos (Dasypus novemcinctus) from the Andean region of Colombia. Lepr Rev. 2009;80(4):424–431.
   PubMed Web of Science ®Google Scholar
• Avanzi C, Del-Pozo J, Benjak A, et al. Red squirrels in the British Isles are infected with leprosy bacilli. Science. 2016;354(6313):744–747. DOI:10.1126/science.aah3783
   PubMed Web of Science ®Google Scholar
• Tio-Coma M, Sprong H, Kik M, et al. Lack of evidence for the presence of leprosy bacilli in red squirrels from North-West Europe. Transbound Emerg Dis. 2020;67(2):1032–1034. DOI:10.1111/tbed.13423
   PubMed Web of Science ®Google Scholar
• Donham KJ, Leininger JR. Spontaneous leprosy-like disease in a chimpanzee. J Infect Dis. 1977;136(1):132–136.
   PubMed Web of Science ®Google Scholar
• Leininger JR, Donham KJ, Rubino MJ. Leprosy in a chimpanzee. Morphology of the skin lesions and characterization of the organism. Vet Pathol. 1978;15(3):339–346.
   PubMed Web of Science ®Google Scholar
• Hubbard GB, Lee DR, Eichberg JW, et al. Spontaneous leprosy in a chimpanzee (Pan troglodytes). Vet Pathol. 1991;28(6):546–548.
   PubMed Web of Science ®Google Scholar
• Gormus BJ, Xu KY, Alford PL, et al. A serologic study of naturally acquired leprosy in chimpanzees. Int J Lepr Other Mycobact Dis. 1991;59(3):450–457.
   PubMedGoogle Scholar
• Hockings KJ, Mubemba B, Avanzi C, et al. Leprosy in wild chimpanzees. Nature. 2021;598(7882):652–656. DOI:10.1038/s41586-021-03968-4
   PubMed Web of Science ®Google Scholar
• Tongluan N, Shelton LT, Collins JH, et al. Mycobacterium leprae infection in ticks and tick-derived cells. Front Microbiol. 2021;12:761420.
   PubMed Web of Science ®Google Scholar
• Ferreira JDS, Souza Oliveira DA, Santos JP, et al. Ticks as potential vectors of Mycobacterium leprae: use of tick cell lines to culture the bacilli and generate transgenic strains. PLoS Negl Trop Dis. 2018;12(12):e0007001. DOI:10.1371/journal.pntd.0007001
   PubMed Web of Science ®Google Scholar
• Bechara GH, Szabo MP, Almeida Filho WV, et al. Ticks associated with armadillo (Euphractus sexcinctus) and anteater (Myrmecophaga tridactyla) of Emas National Park, State of Goias, Brazil. Ann N Y Acad Sci. 2002;969(1):290–293. DOI:10.1111/j.1749-6632.2002.tb04394.x
   PubMedGoogle Scholar
• Neumann Ada S, Dias Fde A, Ferreira Jda S, et al. Experimental infection of Rhodnius prolixus (Hemiptera, Triatominae) with Mycobacterium leprae indicates potential for leprosy transmission. PLoS One. 2016;11(5):e0156037. DOI:10.1371/journal.pone.0156037
   PubMed Web of Science ®Google Scholar
• Wheat WH, Casali AL, Thomas V, et al. Long-term survival and virulence of Mycobacterium leprae in amoebal cysts. PLoS Negl Trop Dis. 2014;8(12):e3405. DOI:10.1371/journal.pntd.0003405
   PubMed Web of Science ®Google Scholar
• Lahiri R, Krahenbuhl JL. The role of free-living pathogenic amoeba in the transmission of leprosy: a proof of principle. Lepr Rev. 2008;79(4):401–409.
   PubMed Web of Science ®Google Scholar
• Singh V, Turankar RP, Goel A. Real-time PCR-based quantitation of viable Mycobacterium leprae strain from clinical samples and environmental sources and its genotype in multi-case leprosy families of India. Eur J Clin Microbiol Infect Dis. 2020;39(11):2045–2055.
   PubMed Web of Science ®Google Scholar
• Holanda MV, Marques LEC, Macedo MLB, et al. Presence of Mycobacterium leprae genotype 4 in environmental waters in Northeast Brazil. Rev Soc Bras Med Trop. 2017;50(2):216–222. DOI:10.1590/0037-8682-0424-2016
   PubMed Web of Science ®Google Scholar
• Scollard DM, McCormick G, Allen JL. Localization of Mycobacterium leprae to endothelial cells of epineurial and perineurial blood vessels and lymphatics. Am J Pathol. 1999;154(5):1611–1620.
   PubMed Web of Science ®Google Scholar
• Rambukkana A. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Curr Opin Microbiol. 2001;4(1):21–27.
   PubMed Web of Science ®Google Scholar
• Rambukkana A, Yamada H, Zanazzi G, et al. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science. 1998;282(5396):2076–2079. DOI:10.1126/science.282.5396.2076
   PubMed Web of Science ®Google Scholar
• Harboe M, Aseffa A, Leekassa R. Challenges presented by nerve damage in leprosy. Lepr Rev. 2005;76(1):5–13.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, DiMario PJ, Grove A. Mycobacterium smegmatis histone-like protein Hlp is nucleoid associated. FEMS Microbiol Lett. 2009;291(2):232–240.
   PubMed Web of Science ®Google Scholar
• Shimoji Y, Ng V, Matsumura K, et al. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A. 1999;96(17):9857–9862.
   PubMed Web of Science ®Google Scholar
• Medeiros MF, Rodrigues MM, Vital RT, et al. CXCL10, MCP-1, and other immunologic markers involved in neural leprosy. Appl Immunohistochem Mol Morphol. 2015;23(3):220–229. DOI:10.1097/PAI.0000000000000074
   PubMedGoogle Scholar
• Schön T, Hernández-Pando R, Baquera-Heredia J, et al. Nitrotyrosine localization to dermal nerves in borderline leprosy. Br J Dermatol. 2004;150(3):570–574. DOI:10.1046/j.1365-2133.2004.05764.x
   PubMed Web of Science ®Google Scholar
• Tapinos N, Ohnishi M, Rambukkana A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med. 2006;12(8):961–966.
   PubMed Web of Science ®Google Scholar
• Noon LA, Lloyd AC. Treating leprosy: an Erb-al remedy? Trends Pharmacol Sci. 2007;28(3):103–105.
   PubMed Web of Science ®Google Scholar
• Spierings E, de Boer T, Wieles B, et al. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. J Immunol. 2001;166(10):5883–5888.
   PubMed Web of Science ®Google Scholar
• Khanolkar-Young S, Rayment N, Brickell PM, et al. Tumour necrosis factor-alpha (TNF-α) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol. 1995;99(2):196–202. DOI:10.1111/j.1365-2249.1995.tb05532.x
   PubMed Web of Science ®Google Scholar
• Conti G, De Pol A, Scarpini E, et al. Interleukin-1 β and interferon-γ induce proliferation and apoptosis in cultured Schwann cells. J Neuroimmunol. 2002;124(1–2):29–35. DOI:10.1016/S0165-5728(02)00003-6
   PubMed Web of Science ®Google Scholar
• El Idrissi N B, Das PK, Fluiter K, et al. M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator. Acta Neuropathol. 2015;129(5):653–667. DOI:10.1007/s00401-015-1404-5
   PubMed Web of Science ®Google Scholar
• Gomes GI, Nahn EP Jr., Santos RK, et al. The functional state of the complement system in leprosy. Am J Trop Med Hyg. 2008;78(4):605–610.
   PubMed Web of Science ®Google Scholar
• Rodrigues LS, da Silva Maeda E, Moreira ME, et al. Mycobacterium leprae induces insulin-like growth factor and promotes survival of Schwann cells upon serum withdrawal. Cell Microbiol. 2010;12(1):42–54. DOI:10.1111/j.1462-5822.2009.01377.x
   PubMed Web of Science ®Google Scholar
• Medeiros RCA, Girardi K, Cardoso FKL, et al. Subversion of Schwann cell glucose metabolism by Mycobacterium leprae. J Biol Chem. 2016;291(47):24803. DOI:10.1074/jbc.A116.725283
   PubMed Web of Science ®Google Scholar
• Mattos KA, Oliveira VG, D’Avila H, et al. TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence. J Immunol. 2011;187(5):2548–2558. DOI:10.4049/jimmunol.1101344
   PubMed Web of Science ®Google Scholar
• Mattos KA, Lara FA, Oliveira VG, et al. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol. 2011;13(2):259–273. DOI:10.1111/j.1462-5822.2010.01533.x
   PubMed Web of Science ®Google Scholar
• Diaz Acosta CC, Dias AA, Rosa T, et al. PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves. PLoS Pathog. 2018;14(7):e1007151. DOI:10.1371/journal.ppat.1007151
   PubMed Web of Science ®Google Scholar
• Masaki T, Qu J, Cholewa-Waclaw J, et al. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell. 2013;152(1–2):51–67.
   PubMed Web of Science ®Google Scholar
• Masaki T, McGlinchey A, Cholewa-Waclaw J, et al. Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. Cell Reprogram. 2014;16(1):9–17.
   PubMed Web of Science ®Google Scholar
• Eiglmeier K, Parkhill J, Honore N, et al. The decaying genome of Mycobacterium leprae. Lepr Rev. 2001;72(4):387–398. DOI:10.5935/0305-7518.20010047
   PubMed Web of Science ®Google Scholar
• Mattos KA, Oliveira VC, Berredo-Pinho M, et al. Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. Cell Microbiol. 2014;16(6):797–815. DOI:10.1111/cmi.12279
   PubMed Web of Science ®Google Scholar
• Medeiros RC, Girardi KD, Cardoso FK, et al. Subversion of Schwann cell glucose metabolism by Mycobacterium leprae. J Biol Chem. 2016;291(41):21375–21387. DOI:10.1074/jbc.M116.725283
   PubMed Web of Science ®Google Scholar
• Sztalryd C, Kimmel AR. Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection. Biochimie. 2014;96:96–101.
   PubMed Web of Science ®Google Scholar
• Coleman RA, Mashek DG. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem Rev. 2011;111(10):6359–6386.
   PubMed Web of Science ®Google Scholar
• Chatterjee KR, Das Gupta NN, De ML. Electron microscopic observations on the morphology of Mycobacterium leprae. Exp Cell Res. 1959;18(3):521–527.
   PubMed Web of Science ®Google Scholar
• Tanigawa K, Luo Y, Kawashima A, et al. Essential roles of PPARs in lipid metabolism during mycobacterial infection. Int J Mol Sci. 2021;22(14):7597. DOI:10.3390/ijms22147597
   PubMed Web of Science ®Google Scholar
• Targett-Adams P, McElwee MJ, Ehrenborg E, et al. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta. 2005;1728(1–2):95–104.
   PubMedGoogle Scholar
• Lu B, Jiang YJ, Kim P, et al. Expression and regulation of GPAT isoforms in cultured human keratinocytes and rodent epidermis. J Lipid Res. 2010;51(11):3207–3216. DOI:10.1194/jlr.M007054
   PubMed Web of Science ®Google Scholar
• Vander Beken S, Al Dulayymi JR, Naessens T, et al. Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol. 2011;41(2):450–460. DOI:10.1002/eji.201040719
   PubMed Web of Science ®Google Scholar
• Kai M, Fujita Y, Maeda Y, et al. Identification of trehalose dimycolate (cord factor) in Mycobacterium leprae. FEBS Lett. 2007;581(18):3345–3350. DOI:10.1016/j.febslet.2007.06.029
   PubMed Web of Science ®Google Scholar
• Barry CE 3rd, Lee RE, Mdluli K, et al. Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res. 1998;37(2–3):143–179. DOI:10.1016/S0163-7827(98)00008-3
   PubMed Web of Science ®Google Scholar
• Cabruja M, Mondino S, Tsai YT, et al. A conditional mutant of the fatty acid synthase unveils unexpected cross talks in mycobacterial lipid metabolism. Open Biol. 2017;7(2):160277.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Wkly Epidemiol Rec. 2021;96(36):421–444.
   Google Scholar
• Kumar DP, Uprety S, Dogra S. Clinical diagnosis of leprosy. In: Scollard D T Gillis, editors. International textbook of leprosy; 2017.
   Google Scholar
• Bechelli LM. Indeterminate leprosy in a population survey and in the subsequent follow-ups of children in Burma. Acta Leprol. 1989;7(1):29–36.
   PubMedGoogle Scholar
• Ridley DS, Hilson GR. A logarithmic index of bacilli in biopsies. I. Method. Int J Lepr Other Mycobact Dis. 1967;35(2):184–186.
   PubMedGoogle Scholar
• Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ. 1974;51(5):451–465.
   PubMed Web of Science ®Google Scholar
• Rodrigues Junior IA, Gresta LT, Noviello Mde L, et al. Leprosy classification methods: a comparative study in a referral center in Brazil. Int J Infect Dis. 2016;45:118–122.
   PubMed Web of Science ®Google Scholar
• Chan MMF, Smoller BR. Overview of the histopathology and other laboratory investigations in leprosy. Curr Trop Med Rep. 2016;3(4):131–137.
   Google Scholar
• Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19(2):338–381.
   PubMed Web of Science ®Google Scholar
• Massone C, Belachew WA, Schettini A. Histopathology of the lepromatous skin biopsy. Clin Dermatol. 2015;33(1):38–45.
   PubMed Web of Science ®Google Scholar
• Martinez AN, Talhari C, Moraes MO, et al. PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic. PLoS Negl Trop Dis. 2014;8(4):e2655.
   PubMed Web of Science ®Google Scholar
• Manta FSN, Jacomasso T, Rampazzo RCP, et al. Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis. PLoS Negl Trop Dis. 2022;16(2):e0009850. DOI:10.1371/journal.pntd.0009850
   PubMed Web of Science ®Google Scholar
• Pathak VK, Singh I, Turankar RP, et al. Utility of multiplex PCR for early diagnosis and household contact surveillance for leprosy. Diagn Microbiol Infect Dis. 2019;95(3):114855. DOI:10.1016/j.diagmicrobio.2019.06.007
   PubMed Web of Science ®Google Scholar
• Buhrer SS, Smits HL, Gussenhoven GC, et al. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg. 1998;58(2):133–136.
   PubMed Web of Science ®Google Scholar
• Burdick AE, Ramirez CC. The role of mycophenolate mofetil in the treatment of leprosy reactions. Int J Lepr Other Mycobact Dis. 2005;73(2):127–128.
   PubMedGoogle Scholar
• Silva K, de Oliveira EE, Elias CMM, et al. Serum IgA antibodies specific to M. leprae antigens as biomarkers for leprosy detection and household contact tracking. Front Med. 2021;8:698495.
   PubMed Web of Science ®Google Scholar
• Spencer JS, Kim HJ, Wheat WH, et al. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol. 2011;18(2):260–267. DOI:10.1128/CVI.00472-10
   PubMedGoogle Scholar
• Amorim FM, Nobre ML, Nascimento LS, et al. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. PLoS Negl Trop Dis. 2019;13(1):e0007089. DOI:10.1371/journal.pntd.0007089
   PubMed Web of Science ®Google Scholar
• Levis WR, Meeker HC, Schuller-Levis G, et al. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence. J Invest Dermatol. 1986;86(5):529–534.
   PubMed Web of Science ®Google Scholar
• Parkash O, Singh HB, Rai S, et al. Detection of Mycobacterium leprae DNA for 36kda protein in urine from leprosy patients: a preliminary report. Rev Inst Med Trop Sao Paulo. 2004;46(5):275–277.
   PubMedGoogle Scholar
• Patil SA, Katoch K, Ramu G, et al. Detection of antibodies against phenolic glycolipid-1 (PGL-1), 35-kDa and 30-40-kDa components of Mycobacterium leprae in the cerebrospinal fluid of leprosy patients. J Med Microbiol. 1995;43(2):115–119.
   PubMed Web of Science ®Google Scholar
• Patil SA, Tyagi P, Katoch K, et al. Antigens of Mycobacterium leprae in the cerebrospinal fluid of leprosy patients: detection by monoclonal-antibody-based sandwich immunoradiometric assay and avidin/biotin immunoblotting. Clin Exp Immunol. 1991;84(3):515–521.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization. Regional Office for South-East Asia; 2018.
   Google Scholar
• World Health Organization. WHO expert committee on leprosy. World Health Organ Tech Rep Ser. 2010;968:1–61.
   Web of Science ®Google Scholar
• Brandsma J, Post E, Wagenaar I, et al. Pure neural leprosy—mind the diagnosis. Lepr Rev. 2021;92(1):38–46. DOI:10.47276/lr.92.1.38
   Web of Science ®Google Scholar
• Kumar B, Kaur I, Dogra S, et al. Pure neuritic leprosy in India: an appraisal. Int J Lepr Other Mycobact Dis. 2004;72(3):284–290.
   PubMedGoogle Scholar
• Kumar B. Pure or Primary neuritic Leprosy (PNL). Lepr Rev. 2016;87(4):450–455.
   PubMed Web of Science ®Google Scholar
• Rao PN, Suneetha S. Pure neuritic leprosy: current status and relevance. Indian J Dermatol Venereol Leprol. 2016;82(3):252–261.
   PubMed Web of Science ®Google Scholar
• Pitta IJR, Hacker MAV, Andrade LR, et al. Follow-up assessment of patients with pure neural leprosy in a reference center in Rio de Janeiro-Brazil. PLoS Negl Trop Dis. 2022;16(1):e0010070. DOI:10.1371/journal.pntd.0010070
   PubMed Web of Science ®Google Scholar
• Lockwood DN, Saunderson PR. Nerve damage in leprosy: a continuing challenge to scientists, clinicians and service providers. Int Health. 2012;4(2):77–85.
   PubMed Web of Science ®Google Scholar
• Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int J Lepr Other Mycobact Dis. 2004;72(2):125–133.
   PubMedGoogle Scholar
• Scollard DM, Smith T, Bhoopat L, et al. Epidemiologic characteristics of leprosy reactions. Int J Lepr Other Mycobact Dis. 1994;62(4):559–567.
   PubMedGoogle Scholar
• Ranque B, Nguyen VT, Vu HT, et al. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy. Clin Infect Dis. 2007;44(1):33–40. DOI:10.1086/509923
   PubMed Web of Science ®Google Scholar
• Pandhi D, Chhabra N. New insights in the pathogenesis of type 1 and type 2 lepra reaction. Indian J Dermatol Venereol Leprol. 2013;79(6):739–749.
   PubMed Web of Science ®Google Scholar
• Fonseca AB, Simon MD, Cazzaniga RA, et al. The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy. Infect Dis Poverty. 2017;6(1):5. DOI:10.1186/s40249-016-0229-3
   PubMedGoogle Scholar
• Verhagen CE, Wierenga EA, Buffing AA, et al. Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol. 1997;159(9):4474–4483.
   PubMed Web of Science ®Google Scholar
• Modlin RL, Melancon-Kaplan J, Young SM, et al. Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A. 1988;85(4):1213–1217. DOI:10.1073/pnas.85.4.1213
   PubMed Web of Science ®Google Scholar
• Moraes MO, Sarno EN, Almeida AS, et al. Cytokine mRNA expression in leprosy: a possible role for interferon-γ and interleukin-12 in reactions (RR and ENL). Scand J Immunol. 1999;50(5):541–549. DOI:10.1046/j.1365-3083.1999.00622.x
   PubMed Web of Science ®Google Scholar
• Stefani MM, Martelli CM, Gillis TP, et al. In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression. J Infect Dis. 2003;188(7):1024–1031.
   PubMed Web of Science ®Google Scholar
• Schmitz V, Prata RB, Barbosa MG, et al. Expression of CD64 on circulating neutrophils favoring systemic inflammatory status in erythema nodosum leprosum. PLoS Negl Trop Dis. 2016;10(8):e0004955. DOI:10.1371/journal.pntd.0004955
   PubMed Web of Science ®Google Scholar
• Bhat RM, Vaidya TP. What is new in the pathogenesis and management of erythema nodosum leprosum. Indian Dermatol Online J. 2020;11(4):482–492.
   PubMedGoogle Scholar
• Negera E, Walker SL, Bekele Y, et al. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions. PLoS Negl Trop Dis. 2017;11(12):e0006121.
   PubMed Web of Science ®Google Scholar
• Sahu S, Sharma K, Sharma M, et al. Neutrophil NETworking in ENL: potential as a putative biomarker: future insights. Front Med. 2021;8:697804.
   Web of Science ®Google Scholar
• Walker SL, Balagon M, Darlong J, et al. ENLIST 1: an international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum. PLoS Negl Trop Dis. 2015;9(9):e0004065. DOI:10.1371/journal.pntd.0004065
   PubMed Web of Science ®Google Scholar
• Voorend CG, Post EB. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Negl Trop Dis. 2013;7(10):e2440.
   PubMed Web of Science ®Google Scholar
• Dharmawan Y, Fuady A, Korfage I, et al. Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis. 2021;15(8):e0009651.
   PubMed Web of Science ®Google Scholar
• B SG. The history of leprosy. In: RC H, editor. Leprosy. 1st ed. Edinburgh (Scotland) and New York: Churchill Livingstone; 1985. p. 1–14.
   Google Scholar
• Bennett BH, Parker DL, Robson M. Leprosy: steps along the journey of eradication. Public Health Rep. 2008;123(2):198–205.
   PubMed Web of Science ®Google Scholar
• Wolcott RR, Ross H. Exacerbation of leprosy during present day treatment. Int J Lepr. 1953;21(4:1):437–440.
   PubMedGoogle Scholar
• World Health Organization. A guide for surveillance of antimicrobial resistance in leprosy: 2017 update. 2017. India: WHO.
   Google Scholar
• World Health Organization. Chemotherapy of leprosy. World Health Organ Tech Rep Ser. 1994;847:1–24.
   PubMedGoogle Scholar
• Vedithi SC, Malhotra S, Das M, et al. Structural implications of mutations conferring rifampin resistance in Mycobacterium leprae. Sci Rep. 2018;8(1):5016. DOI:10.1038/s41598-018-23423-1
   PubMedGoogle Scholar
• Aristoff PA, Garcia GA, Kirchhoff PD, et al. Rifamycins–obstacles and opportunities. Tuberculosis. 2010;90(2):94–118.
   PubMed Web of Science ®Google Scholar
• Seydel JK, Richter M, Wempe E. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA). Int J Lepr Other Mycobact Dis. 1980;48(1):18–29.
   PubMedGoogle Scholar
• Chaitanya VS, Das M, Bhat P, et al. Computational modelling of dapsone interaction with dihydropteroate synthase in Mycobacterium leprae; insights into molecular basis of dapsone resistance in leprosy. J Cell Biochem. 2015;116(10):2293–2303.
   PubMed Web of Science ®Google Scholar
• Kai M, Matsuoka M, Nakata N, et al. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett. 1999;177(2):231–235. DOI:10.1111/j.1574-6968.1999.tb13737.x
   PubMed Web of Science ®Google Scholar
• Maeda S, Matsuoka M, Nakata N, et al. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother. 2001;45(12):3635–3639. DOI:10.1128/AAC.45.12.3635-3639.2001
   PubMed Web of Science ®Google Scholar
• Williams DL, Spring L, Harris E, et al. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrob Agents Chemother. 2000;44(6):1530–1537.
   PubMed Web of Science ®Google Scholar
• Warndorff-van Diepen T. Clofazimine-resistant leprosy, a case report. Int J Lepr Other Mycobact Dis. 1982;50(2):139–142.
   PubMedGoogle Scholar
• Kar HK, Bhatia VN, Harikrishnan S. Combined clofazimine- and dapsone-resistant leprosy. A case report. Int J Lepr Other Mycobact Dis. 1986;54(3):389–391.
   PubMedGoogle Scholar
• Williams DL, Gillis TP. Drug-resistant leprosy: monitoring and current status. Lepr Rev. 2012;83(3):269–281.
   PubMed Web of Science ®Google Scholar
• Drlica K, Xu C, Wang JY, et al. Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity. Antimicrob Agents Chemother. 1996;40(7):1594–1599.
   PubMed Web of Science ®Google Scholar
• Cambau E, Perani E, Guillemin I, et al. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet. 1997;349(9045):103–104.
   PubMed Web of Science ®Google Scholar
• Jacobson RR, Hastings RC. Rifampin-resistant leprosy. Lancet. 1976;2(7998):1304–1305.
   PubMed Web of Science ®Google Scholar
• Contreras Mejia Mdel C, Porto Dos Santos M, Villarouco da Silva GA, et al. Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil. J Clin Microbiol. 2014;52(12):4359–4360. DOI:10.1128/JCM.01688-14
   PubMed Web of Science ®Google Scholar
• Lavania M, Jadhav RS, Chaitanya VS, et al. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending the leprosy mission (TLM) hospitals in India. Lepr Rev. 2014;85(3):177–185. DOI:10.47276/lr.85.3.177
   PubMed Web of Science ®Google Scholar
• Lavania M, Nigam A, Turankar RP, et al. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India. Clin Microbiol Infect. 2015;21(12):e85–6. DOI:10.1016/j.cmi.2015.08.004
   PubMed Web of Science ®Google Scholar
• Cambau E, Saunderson P, Matsuoka M, et al. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. Clin Microbiol Infect. 2018;24(12):1305–1310. DOI:10.1016/j.cmi.2018.02.022
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Kashiwabara Y, Namisato M. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int J Lepr Other Mycobact Dis. 2000;68(4):452–455.
   PubMedGoogle Scholar
• Nakata N, Kai M, Makino M. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance. Antimicrob Agents Chemother. 2011;55(2):762–766.
   PubMed Web of Science ®Google Scholar
• Hasanoor Reja AH, Biswas N, Biswas S, et al. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India. Indian J Dermatol Venereol Leprol. 2015;81(2):155–161. DOI:10.4103/0378-6323.152185
   PubMed Web of Science ®Google Scholar
• Sekar B, Arunagiri K, Kumar BN, et al. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing–a rapid tool for screening drug resistance in leprosy. Lepr Rev. 2011;82(1):36–45.
   PubMed Web of Science ®Google Scholar
• da Silva PEA, Machado D, Ramos D, et al. Efflux pumps in mycobacteria: antimicrobial resistance, physiological functions, and role in pathogenicity. In: Li X-Z, C Elkins H Zgurskaya, editors. Efflux-mediated antimicrobial resistance in bacteria: mechanisms, regulation and clinical implications. Cham: Springer International Publishing; 2016. p. 527–559.
   Google Scholar
• . Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga prevention trial group. Lancet. 1996;348(9019):17–24. 10.1016/S0140-6736(96)02166-6.
   PubMed Web of Science ®Google Scholar
• Setia MS, Steinmaus C, Ho CS, et al. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis. 2006;6(3):162–170.
   PubMed Web of Science ®Google Scholar
• Duthie MS, Gillis TP, Reed SG. Advances and hurdles on the way toward a leprosy vaccine. Hum Vaccin. 2011;7(11):1172–1183.
   PubMed Web of Science ®Google Scholar
• Zodpey SP. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian J Dermatol Venereol Leprol. 2007;73(2):86–93.
   PubMed Web of Science ®Google Scholar
• Merle CS, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines. 2010;9(2):209–222.
   PubMed Web of Science ®Google Scholar
• Sharma P, Mukherjee R, Talwar GP, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr Rev. 2005;76(2):127–143. DOI:10.47276/lr.76.2.127
   PubMed Web of Science ®Google Scholar
• Kumaran MS, Narang T, Chabbra S, et al. Mycobacterium indicus pranii vaccine immunoprophylaxis in anti-phenolic glycolipid-1-positive leprosy contacts - a pilot study from a tertiary care center in North India. Indian J Dermatol Venereol Leprol. 2021;88(1):47–50.
   PubMed Web of Science ®Google Scholar
• Ali L. Leprosy vaccines – a voyage unfinished. Journal of Skin and Sexually Transmitted Diseases. 2021;3:40–45.
   Google Scholar
• Mieras LF, Taal AT, van Brakel WH, et al. An enhanced regimen as post-exposure chemoprophylaxis for leprosy: pEP+. BMC Infect Dis. 2018;18(1):506. DOI:10.1186/s12879-018-3402-4
   PubMedGoogle Scholar
• Richardus JH, Tiwari A, Barth-Jaeggi T, et al. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. Lancet Glob Health. 2021;9(1):e81–90. DOI:10.1016/S2214-109X(20)30396-X
   PubMed Web of Science ®Google Scholar
• Reveiz L, Buendia JA, Tellez D. Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis. Rev Panam Salud Publica. 2009;26(4):341–349.
   PubMed Web of Science ®Google Scholar
• Moet FJ, Pahan D, Oskam L, et al. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;336(7647):761–764.
   PubMedGoogle Scholar
• Bakker MI, Hatta M, Kwenang A, et al. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72(4):443–448. DOI:10.4269/ajtmh.2005.72.443
   PubMed Web of Science ®Google Scholar
• Cree IA, Smith WC. Leprosy transmission and mucosal immunity: towards eradication? Lepr Rev. 1998;69(2):112–121.
   PubMed Web of Science ®Google Scholar
• Beyene D, Aseffa A, Harboe M, et al. Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia. Epidemiol Infect. 2003;131(2):841–848. DOI:10.1017/S0950268803001079
   PubMed Web of Science ®Google Scholar
• Fine PE, Sterne JA, Ponnighaus JM, et al. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol. 1997;146(1):91–102. DOI:10.1093/oxfordjournals.aje.a009195
   PubMed Web of Science ®Google Scholar
• Moet FJ, Pahan D, Schuring RP, et al. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis. 2006;193(3):346–353.
   PubMed Web of Science ®Google Scholar
• Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect. 2000;41(2):137–142.
   PubMed Web of Science ®Google Scholar